Biotech & Health
H1 secures $40M from CVS, proving SaaS startups can still attract investment
CEO Ariel Katz argues that while AI can replicate workflow SaaS, it can't copy H1’s unique doctor data.
This browser does not support voice playback. Try Chrome, Edge or Safari.